10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q3 2015

Filing Information

Form Type	10-Q
Accession Number	`0000946644-15-000067`
Period End Date	20150930
Filing Date	20151116
Fiscal Year	2015
Fiscal Period	Q3
XBRL Instance	heb-20150930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 65 Income Statement 65 Cash Flow Statement 54 Stockholders Equity 10

Balance Sheet 65 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.16M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.26M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$11.21M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$13.95M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	$1.33M	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	-	USD	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	-	USD	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	-	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$399.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$278.00K	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$13.98M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	247.56M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$16.51M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	204.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.60M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	204.00M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	247.56M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.50M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$861.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$883.00K	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$7.34M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	-	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$134.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$134.00K	USD	Point-in-time
Total assets	`Assets`	$26.50M	USD	Point-in-time
Total assets	`Assets`	$29.44M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.08M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.51M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.82M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.33M	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$22.00K	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$3.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.44M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.33M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 247,557,287 and 204,004,818, respectively	`CommonStockValue`	$204.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 247,557,287 and 204,004,818, respectively	`CommonStockValue`	$248.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$302.73M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$313.19M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-401.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-160.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-277.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-289.86M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$23.17M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.00M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$29.44M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$26.50M	USD	Point-in-time

Income Statement 65 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs	`SalesRevenueGoodsNet`	$157.00K	USD	3 Qtrs
Clinical treatment programs	`SalesRevenueGoodsNet`	$106.00K	USD	3 Qtrs
Clinical treatment programs	`SalesRevenueGoodsNet`	$45.00K	USD	1 Quarter
Clinical treatment programs	`SalesRevenueGoodsNet`	$23.00K	USD	1 Quarter
Total revenues	`Revenues`	$106.00K	USD	3 Qtrs
Total revenues	`Revenues`	$23.00K	USD	1 Quarter
Total revenues	`Revenues`	$45.00K	USD	1 Quarter
Total revenues	`Revenues`	$157.00K	USD	3 Qtrs
Production	`CostOfRevenue`	$1.23M	USD	3 Qtrs
Production	`CostOfRevenue`	$353.00K	USD	1 Quarter
Production	`CostOfRevenue`	$923.00K	USD	3 Qtrs
Production	`CostOfRevenue`	$306.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$7.08M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.89M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.97M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$6.55M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.69M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.17M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.21M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.60M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$4.01M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$14.68M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$4.37M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$13.91M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.98M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-14.53M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-4.33M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-13.81M	USD	3 Qtrs
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$9.00K	USD	3 Qtrs
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$3.00K	USD	3 Qtrs
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$1.00K	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$3.00K	USD	1 Quarter
Interest and other income/expense	`OtherInterestAndDividendIncome`	$343.00K	USD	3 Qtrs
Interest and other income/expense	`OtherInterestAndDividendIncome`	$130.00K	USD	1 Quarter
Interest and other income/expense	`OtherInterestAndDividendIncome`	$414.00K	USD	3 Qtrs
Interest and other income/expense	`OtherInterestAndDividendIncome`	$181.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-1.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.13M	USD	3 Qtrs
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.37M	USD	3 Qtrs
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	-	USD	1 Quarter
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	-	USD	1 Quarter
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.37M	USD	Point-in-time
Net loss	`ProfitLoss`	$-12.99M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-3.80M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.20M	USD	1 Quarter
Net loss	`ProfitLoss`	$-12.09M	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$-169.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$-241.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$-215.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	-	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.02M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-12.33M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-12.99M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.37M	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	3 Qtrs
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	3 Qtrs
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	232.31M	shares	3 Qtrs
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	184.43M	shares	3 Qtrs
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	246.77M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	190.68M	shares	1 Quarter

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-12.99M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-3.80M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.20M	USD	1 Quarter
Net loss	`ProfitLoss`	$-12.09M	USD	3 Qtrs
Depreciation of property and equipment	`Depreciation`	$663.00K	USD	3 Qtrs
Depreciation of property and equipment	`Depreciation`	$500.00K	USD	3 Qtrs
Amortization and abandonment of patent and trademark rights	`AdjustmentForAmortization`	$414.00K	USD	3 Qtrs
Amortization and abandonment of patent and trademark rights	`AdjustmentForAmortization`	$166.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-1.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Equity-based compensation	`StockOptionPlanExpense`	$260.00K	USD	3 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$148.00K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	-	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$1.33M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-123.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-121.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$97.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.21M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$553.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-515.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.74M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.93M	USD	3 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$386.00K	USD	3 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$226.00K	USD	3 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$188.00K	USD	3 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$187.00K	USD	3 Qtrs
Deposits on capital leases refunded	`ProceedsfromRefundofCapitalLeaseDeposits`	$2.00K	USD	3 Qtrs
Deposits on capital leases refunded	`ProceedsfromRefundofCapitalLeaseDeposits`	-	USD	3 Qtrs
Sales and maturities of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	$-1.22M	USD	3 Qtrs
Sales and maturities of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	$-2.50M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$651.00K	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.08M	USD	3 Qtrs
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$19.00K	USD	3 Qtrs
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$24.00K	USD	3 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$9.76M	USD	3 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$9.68M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.66M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.74M	USD	3 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$459.00K	USD	3 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-995.00K	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.16M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.26M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.26M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Issuance of common stock for accounts payable	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$672.00K	USD	3 Qtrs
Issuance of common stock for accounts payable	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$38.00K	USD	3 Qtrs
Cash paid for interest expense	`InterestPaid`	$-9.00K	USD	3 Qtrs
Cash paid for interest expense	`InterestPaid`	$-3.00K	USD	3 Qtrs

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$23.17M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.00M	USD	Point-in-time
Shares to settle accounts payable	`StockIssuedDuringPeriodValueIssuedForServices`	$672.00K	USD	3 Qtrs
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$148.00K	USD	3 Qtrs
Stock sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$9.68M	USD	3 Qtrs
Net comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-12.33M	USD	3 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$23.17M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.00M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.